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Menzoian,  MD,  Boston, Mass. 
Purpose: To determine the effect of a critical pathway on postoperative l ngth of stay 
and outcomes after infrainguinal bypass. 
Methods: A critical pathway for care of patients after infrainguinal bypass was introduced 
in December 1995 to coordinate postoperative care at our institution. We compared care 
of 67 consecutively treated patients before institution of the pathway with care of 69 con- 
secutively treated patients with the critical pathway in place. Data collection was done by 
means of chart review. Univariate analyses were used to identify differences between 
prepathway and postpathway patients and to identify factors influencing postoperative 
length of stay. Multivariate analysis was used to identify factors that influenced length of 
stay and to examine the effect of use of the pathway after adjusting for other factors. 
Results: Patients on the pathway were similar to prepathway controls with respect o 
comorbid illnesses, vascular isk factors, indications for surgical treatment, ype of con- 
duit, and type of operation. Factors associated with longer postoperative stays included 
distal anastomoses to tibial rather than popliteal vessels (p = 0.02), preexisting cardiac 
disease (p = 0.005), postoperative complications (p = 0.0003), lower preoperative h ma- 
tocrit (p = 0.01), and elevated preoperative creatinine level (p = 0.006). Overall, path- 
way patients had somewhat shorter postoperative l ngths of stay (median value 7 days; 
range 2 to 29 days) than prepathway patients (median value 6 days; range 2 to 35; 
p = 0.01), and the two groups had similar frequencies of postoperative complications, 
readmission, and 6-month mortality. However, patients on the pathway were more like- 
ly to be discharged to an intermediate-care facility rather than directly home. After 12 
patients with extraordinarily prolonged postoperative stays were excluded, multivariate 
analysis indicated that pathway patients had significantly shorter postoperative stays 
(p = 0.001). However, the difference was not significant if patients with extraordinarily 
long postoperative stays were included in the analysis (p -- 0.28). 
Conclusion: Use of a critical pathway was associated with a modest decrease in postopera- 
tive length of stay for most patients. This was accomplished without an adverse ffect on 
readmission, complication, or mortality rates. However, the decrease in stay may have been 
achieved primarily by discharging more patients to intermediate-care facilities. The path- 
way did not appear to have any effect when the subset of patients with extraordinarily long 
stays because of complex medical problems was included. (J Vasc Surg 1998;27:1056-65.) 
Critical pathways are designed to establish an 
optimal sequence of diagnostic and treatment inter- 
ventions for a particular diagnosis or procedure to 
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minimize delays in care, to increase fficiency, and to 
improve the quality of  care. Several studies have sug- 
gested that institution of  critical pathways can 
reduce length of stay after peripheral vascular opera- 
tions without having an adverse ffect on morbidity 
or mortality rates. 1-8 However, unbiased evaluation 
of  the effect of critical pathways on peripheral vascu- 
lar operations i made difficult by the chronicity and 
complexity of the underlying disease and the hetero- 
geneity of  the patient population with respect o 
indications for surgical treatment, severity of disease, 
and comorbidities. One study dealt with this prob- 
lem by excluding patients whose preoperative l ngth 
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Table I. Summary of critical pathway 
Stage Activity 
Preoperative period 
Electrocardiogram, chest radiograph, laboratory studies 
Evaluations (medical and cardiac, anesthesia) 
Preoperative teaching 
Vascular imaging (angiography, magnetic resonance imaging) 
Discharge planning and psychosocial evaluation 
Physical therapy consultation if needed 
Review of critical pathway with patient and family 
Assessment of discharge needs 
Day of operation 
Postoperative day 1 
Removal of Foley catheter out 
Food as tolerated 
Activity out of bed, short walks 
Activity teaching 
Postoperative day 2 
Discontinuation f intravenous catheters Oral pain medication 
Dressing changes 
Determination f discharge dispositio n and estimation of discharge date 
Postoperative day 3 
Discontinuation f pulse oximetry 
Monitoring for possible discharge 
Postoperative day 4 
Review or laboratory results 
Completion of discharge sheet and visiting nurse referral if needed 
Dictation of discharge summary 
Monitoring for possible discharge 
Postoperative day 5 
Review of medication, activity, laboratory results 
Complete discharge teaching for medication, activity, wound care, and diet 
Preadmission testing for nonemergency operations 
Recovery to monitored setting 
Transfer to surgical floor 
Removal of epidural catheter 
Medical and cardiac follow-up examinations 
Discontinuation f intake and output 
Activity as desired 
of stay could not be controlled, such as patients with 
emergency admission, inpatients referred for vascu- 
lar operations, patients transferred from other hospi- 
tals, and patients who needed prolonged preopera- 
tive treatment. 1 Although it eliminates ome of the 
heterogeneity, restricting the study population in 
this way excludes asubstantial proportion of patients 
who need vascular operations. Because a restricted 
study population may not provide an accurate mea- 
sure of the true effect of a critical pathway, we 
sought o evaluate the effect of a critical pathway on 
postoperative length of stay by collecting data on all 
patients undergoing infrainguinal bypass on our ser- 
vice. If there were a subset of patients for whom the 
pathway had no effect, it could be identified retro- 
spectively. 
Another problem, particularly for patients whose 
underlying problem is atherosclerotic o clusive dis- 
ease, is that inherently poor vasculature and a high 
prevalence of diabetes, hypertension, and cardiac 
and renal disease predispose patients to postopera- 
tive complications, which can prolong hospitaliza- 
tion substantially. The postoperative l ngth of stay 
for patients undergoing vascular operations conse- 
quently tends to follow a skewed istribution, which 
may be a reflection of comorbid illness. This further 
complicates fair evaluation of the efficacy of a critical 
pathway. 
We implemented a critical pathway for patients 
undergoing infrainguinal bypass and sought o eval- 
uate its effect by comparing postoperative length of 
stay and key outcomes (mortality, morbidity, and 6- 
month readmission frequency) for patients consecu- 
tively treated immediately before and after institu- 
tion of the pathway. The primary goal of our critical 
pathway was safely to minimize postoperative length 
of stay and to maintain low complication and read- 
mission rates. Because many of our patients are 
admitted to our service after transfer from other 
institutions or other services, our pathway was not 
designed to address preoperative l ngth of stay, 
which has been addressed in other studies3, 4 A sec- 
ond goal was to determine the effect of a single 
pathway on the heterogeneous population of 
patients undergoing infrainguinal bypass in our insti- 
tution. Finally, we wanted to examine how evalua- 
tion of a pathway might be affected by prolonged 
length of stay as a result Of postoperative cardiac, 
renal, or wound complications. Accordingly, all 
patients undergoing infrainguinal bypass were 
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Table II. Discharge criteria 
Afebrile, no signs of infection 
Heart rate, respiratory rate, and blood pressure at or near 
baseline 
Adequate nutritional intake and bowel function 
Adequate ambulation or mobility or appropriate physical 
therapy or rehabilitation referral in place 
Laboratory values reviewed and acceptable 
All teaching completed 
Written discharge instructions, prescriptions, and follow-up 
appointment given and reviewed 
placed on the pathway, including patients undergo- 
ing emergency procedures and patients transferred 
from other services and hospitals. 
METHODS 
The main features of the critical pathway are 
outlined in Table I, and discharge criteria are shown 
in Table II. Both pathway and prepathway patients 
had undergone recent chest radiography, and rou- 
tine preoperative complete blood cell counts, serum 
creatinine levels, urinalysis, and electrocardiograms 
were obtained. Other laboratory tests were request- 
ed as dictated by comorbid conditions and general 
health. Medical, cardiac, and anesthesia consulta- 
tions were obtained as deemed necessary on the 
basis of overall health and comorbidities. Patients 
scheduled for elective operations underwent vascu- 
lar imaging (angiography or magnetic resonance 
angiography) before admission and were admitted 
on the day of the operation. Patients transferred 
from other hospitals or services who did not under- 
go prior imaging studies underwent preoperative 
imaging as part of the current hospitalization at our 
institution. Pathway patients also underwent review 
of the pathway, preoperative t aching, physical ther- 
apy consultation, and discharge planning as part of 
preoperative preparation. 
Postoperatively, all patients (pathway and pre- 
pathway) recovered in a monitored setting and were 
transferred to a surgical floor on the first postopera- 
tive day. Patients were not routinely admitted to the 
intensive care unit. They were admitted only if indi- 
cated by preoperative condition or intraoperative 
events. Pathway and prepathway patients underwent 
postoperative electrocardiography and medical con- 
sultation only as required by clinical circumstances. 
The pathway went into effect on December 28, 
1995. All patients who underwent infrainguinal 
bypass in our institution since then were placed on 
the pathway without exception (including those 
who underwent emergency and urgent operations). 
Progress was tracked and recorded to document 
variances from the pathway. For the purpose of this 
study we compared care of the first 69 patients reat- 
ed with the pathway in place (December 28, 1995, 
through February 10, 1997) with that of the last 67 
patients treated before inception of the pathway 
(March 15, 1994, through December 27, 1995). 
For prepathway patients data were collected by 
means of detailed retrospective chart review. For 
pathway patients data were collected prospectively. 
Patient histories, surgical indications, anesthesia 
type, location of bypass vessels, conduit chosen, clin- 
ically significant postoperative complications, and 
discharge data were examined and recorded. A 
patient was considered to have had a clinically sig- 
nificant postoperative complication if any of the fol- 
lowing occurred: unstable angina or myocardial 
infarction, stroke, congestive heart failure, ventricu- 
lar arrhythmia, acute renal failure, graft failure, 
pneumonia, wound complications, cellulitis, or rein- 
tubation. 
Data analysis was conducted with several goals. 
The first goal was to identify factors that influenced 
length of stay after infrainguinal bypass in our 
patient population. The second was to identify dif- 
ferences between prepathway and postpathway 
patients. The third goal was to assess the effect of 
the pathway on length of stay after accounting for 
differences in other factors affecting length of stay. 
Factors associated with length of stay were ini- 
tially explored by means of calculation of Pearson 
correlations for continuous variables and the 
Student test or Wilcoxon rank-sum test to compare 
lengths of stay with respect o categorical variables. 
Differences between prepathway and postpathway 
patients were explored initially with the chi-square 
test or Fisher exact est for categorical variables and 
Student t test or the Wilcoxon rank-sum test for 
continuous variables. For parametric omparisons 
results for groups are reported as mean value +_ 
SEM. The effect of the pathway and other factors 
that potentially influence length of stay were exam- 
ined by means of using multiple linear regression to 
adjust for confounding. All analyses were conducted 
with SAS software (SAS Institute, Cary, N.C.) 
licensed to Boston University. 
RESULTS 
Comparability of prepathway and postpathway 
patients. Table III compares prepathway and post- 
pathway patients with respect to patient characteristics, 
surgical procedures, and frequency of complications, 
death, or readmission within 6 months to ascertain 
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Table III. Comparison of prepathway and postpathway patients with respect to patient characteristics, sur- 
gical procedures, and outcomes 
Characteristic Prepathway Postpathway p Value 
Male (%) 63 58 0.6 
White (%) 73 74 0.9 
Living alone (%) 28 30 0.8 
Age (yr; mean _+ SEM) 67.8 _+ 1.3 68.4 +_ 1.3 0.8 
Body mass index (mean ± SEM) 25.0 ± 0.5 24.4 + 0.6 0.5 
Hematocrit (mean + SEM) 38.1 + 0.7 38.2 ± 0.7 0.9 
Creatinine (mg/dl; mean + SEM) 1.8 + 0.3 1.5 +_ 0.2 0.4 
Comorbidities 
Current smoker (%) 42 42 1.0 
Past smoker (%) 82 75 0.3 
Hypertension (%) 76 75 0.9 
Coronary artery disease (%) 57 51 0.5 
Chronic pulmonary (%) disease 11 12 0.8 
Diabetes mellitus (%) 55 48 0.4 
Indications for surgical t reatment  
Limb salvage (%) 85 75 0.16 
Claudication (%) 15 22 0.3 
Aneurysm (%) 0 3 0.5 
Technical factors 
Urgent operation (%) 12 13 0.8 
Autologous vein (%) 70 68 0.8 
Prosthetic graft (%) 15 19 0.5 
Prosthetic and venous graft (%) 15 13 0.8 
Popliteal anastomosis (%) 40 51 0.2 
Tibial anastomosis (%) 61 49 0.2 
Anesthesia 
General (%) 19 38 0.02 
Epidural (%) 64 34 0.001 
General and epidural (%) 12 25 0.05 
Outcomes 
Postoperative complications (%) 8 16 0.13 
Total length of stay (d) 
Mean value _+ SEM 10.3 _+ 0.7 9.1 _+ 0.7 - -  
Median value and range 9 (3-40) 7 (2-37) 0.02 
Preoperative stay (d) 
Mean value _+ SEM 2.6 + 0.4 2.1 _+ 0.3 - -  
Median value and range 1 (0-14) 1 (0-13) 0.15 
Postoperative stay (d) 
Mean value -+ SEM 7.7 + 0.5 7.1 + 0.6 - -  
Median value and range 7 (2-29) 6 (2-35) 0.01 
Discharge to home (%) 72 45 0.002 
Readmission within 6 months for vascular problems (%) 36 35 0.9 
Death within 6 months (%) 3 4 0.9 
whether there were any systematic differences between 
the two groups. Patient characteristics and preexisting 
illnesses were similar in the two groups. In addition, 
there were no significant differences between prepath- 
way and postpathway patients with respect to indica- 
tions or extent of procedure performed (site of anas- 
tomosis or type of conduit used). 
The method of anesthesia differed in that 
prepathway patients more often received epidural 
anesthesia during the procedure, whereas patients 
on the pathway received general anesthesia more fre- 
quently. These differences were found to be the 
result of administrative and staff changes within the 
anesthesia department rather than any difference in 
the patient population. Although epidural anesthesia 
was used more frequently in treatment of thc 
prepathway group, there was no evidence that this 
had any effect on length of stay. There was no sig- 
nificant difference in length of time of epidural anal- 
gesia between the two groups (prepathway median 
value 2.0 days, range 0 to 5 days; postpathway medi- 
an value 2.0 days, range 0 to 4 days; p = 0.7). 
Patients on the critical pathway had a somewhat 
greater frequency of complications (16%) than 
prepathway patients (8%), although the difference 
was not statistically significant (p = 0.14). Despite 
this, pathway patients had significantly shorter 
lengths of stay (postoperative and total lengths of 
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Table  IV. Patient characteristics and surgical variables influencing postoperative l ngth of  stay: Categorical 
variables* 
Variable 
Length of stay for patients without he factor Length of stay for patients with e factor 
Mean value +_ SEM Median value (range) Mean value + SEM Median value (range) p Value 
Comorbid conditions 
Coronary artery disease 6.3 _+ 0.5 5 (2-29) 8.3 ± 0.6 7 (3-35) 0.0003 
Chronic pulmonary disease 7.0 ± 0.3 6 (2-29) 9.9 ± 2.0 7 (4-35) 0.09 
Diabetes mellims 7.0 ± 0.6 6 (2-35) 7.7 ± 0.5 7 (3-23) 0.02 
Current smoker 7.6 ± 0.4 7 (3-23) 7.0 + 0.7 6 (2-35) 0.02 
Past smoker 7.3 ± 0.5 7 (3-15) 7.4 +_ 0.5 6 (2-35) 0.3 
Indication for surgical treatment 
Limb salvage 5.1 ± 0.4 5 (2-9) 7.9 _+ 0.5 7 (3-35) 0.0002 
Rest pain 7.3 ± 0.5 6 (2-29) 7.6 ± 0.7 7 (3-35) 0.4 
Leg ulcer or gangrene 6.6 ± 0.5 6 (2-35) 8.2 _+ 0.6 7 (3-29) 0.03 
Clandication 7.9 _+ 0.5 7 (3-35) 5.1 + 0.4 4 (2-9) 0.0004 
Aneurysm 7.4 + 0.4 6 (2-35) 5.0 ± 0.1 5 (5-5) 0.3 
Technical factor 
Tibial operation 8.4 ± 0.6 6 (2-14) 6.0 ± 0.4 7 (3-35) 0.0003 
Other factors 
Urgent operation 7.3 ± 0.4 6 (2-35) 7.6 ± 0.8 6 (5-15) 0.4 
Postoperative complications 6.7 + 0.3 6 (2-29) 12.2 ± 1.9 10 (5-35) 0.0001 
Type of anesthesia 
General 7.6 ± 0.5 9 (2-21) 6.7 ± 0.4 8 (3-40) 0.8 
Epidural 6.7 + 0.3 8 (3-22) 8.0 ± 0.7 9 (2-22) 0.6 
General and epidural 7.4 ± 0.5 8 (3-22) 7.0 ± 0.7 8 (2-40) 0.8 
Because length of stay demonstrated a skewed distribution, a nonparametric test (Wilcoxon rank sum test) was used to compare lengths 
of stay. 
Tab le  V. Patient characteristics and surgical vari- 
ables influencing postoperative l ngth of  stay: 
Cont inuous variables correlating with postoperative 
length of  stay 
Variable Correlation coefficient p Value 
Age 0.14 0.1 
Body mass index -0.08 0.4 
Preoperative hematocrit -0.26 0.003 
Preoperative serum creatinine 0.16 0.05 
Duration of operation 0.27 0.002 
Days with epidural analgesia 0.29 0.007 
stay). Patients on the pathway were more likely to be 
discharged to an intermediate-care facility. Most  of  
the prepathway patients were discharged irectly to 
home (72%) compared with only 45% of  the patients 
on the critical pathway. Finally, the frequencies o f  
death or readmission for vascular problems within 6 
months of  discharge were unaffected by institution 
of  the pathway. 
Ident i f icat ion o f  factors inf luencing length o f  
stay. Many factors were examined to determine their 
potential influence on postoperative length of  stay. 
Tables IV and V summarize factors that appeared to 
be associated with differences in postoperative l ngth 
of  stay. The presence of  either diabetes or coexisting 
cardiac disease was associated with a significantly 
longer postoperative length of  stay, possibly because 
of  higher rates of  complications among patients with 
diabetes (30%) than patients without diabetes (13%) 
and a higher rate of  complications among patients 
with coronary  artery disease (24%) than patients 
without a history o f  cardiac disease (15%). Patients 
with chronic pulmonary disease also tended to have 
longer postoperative stays. 
Surgical indications also were predictive o f  
length o f  stay. Patients undergoing revascularization 
for l imb salvage had longer lengths of  stay than did 
patients with disabling claudication. The proximity 
of  the distal anastomosis also was significant. 
Anastomosis to fibial vessels resulted in longer hos- 
pitalizations than popliteal bypasses. 
Epidural anesthesia was used more frequently in 
the treatment o f  prepathway patients, but there was 
no evidence that type o f  anesthesia had any effect on 
postoperative l ngth o f  stay. This held true with both 
univariate testing (Table IV) and when type of  anes- 
thesia was included as a variable in multivariate test- 
ing. On the other hand, there was a positive correla- 
tion between postoperative length of  stay and dura- 
t ion of  epidural analgesia (Table V), a l though the 
durat ion of  epidural analgesia was nearly identical 
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Fig. 1. Frequency distributions for postoperative length of stay for prepathway patients and 
patients on the critical pathway. 
among pathway and prepathway patients. Patients 
with a low preoperative hematocrit or a high preop- 
erative creatinine level also tended to have longer 
postoperative l ngths of stay. As expected, patients 
with postoperative complications had extended hos- 
pital stays. Patients who were discharged home had a 
shorter hospital stay than patients who were dis- 
charged to a rehabilitation or chronic care facility. 
Sex, body mass index, type of conduit, and type 
of anesthesia delivered id not significantly affect 
length of stay. It was interesting to note that patients 
who continued to smoke tended to be discharged 
earlier than nonsmokers (p = 0.02). 
Effect of the critical pathway. Overall, path- 
way patients had somewhat shorter postoperative 
lengths of stay (median value 7 days; range 2 to 29 
days) than prepathway patients (median value 6 
days; range 2 to 35 days; p = 0.01), although Fig. 1 
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shows that the frequency distributions for postoper- 
ative length of stay were skewed because a small 
number of patients had extraordinarily long postop- 
erative stays. The top of Fig. 1 shows that most of 
the prepathway patients had postoperative lengths of 
stay ranging from 2 to 12 days, and there was a more 
or less normal distribution within this range. 
Nevertheless, four prepathway patients had postop- 
erative stays ranging from 14 to 29 days. The lower 
panel of Fig. 1 shows that most of the pathway 
patients also had postoperative stays ranging from 2 
to  11 days, but within this range the lengths of stay 
were shifted somewhat toward shorter lengths of 
stay. In addition, eight pathway patients had postop- 
erative lengths of stay of 14 or more days. 
Because multiple factors appeared to influence 
postoperative l ngth of stay, it was important o 
examine the effect of the pathway after taking into 
account or adjusting for differences in other factors 
that influenced length of stay. Accordingly, multiple 
linear regression was used to adjust for confounding 
and to identify independent determinants ofpostop- 
erative length of stay. Variables independently asso- 
ciated with a significantly increased postoperative 
length of stay included anastomosis to tibial vessels 
(as opposed to popliteal vessels, p = 0.005), preex- 
isting coronary artery disease (p = 0.004), occur- 
rence of a postoperative complication (p = 0.0001), 
and preoperative anemia (p = 0.01). A multivariate 
analysis that included all patients uggested that after 
adjustment for differences in these other factors that 
influenced postoperative stay, patients on the critical 
pathway did not have significantly shorter postoper- 
ative lengths of stay (p = 0.28). 
Frequency distribution of  postoperative 
length of stay: effect of complications and pro- 
longed stay on evaluation of the critical pathway. 
Because of the potentially disproportionate effect of 
the 12 patients with extraordinarily long postopera- 
tive stays (>14 days), we examined this subset in 
greater detail. All 12 patients had conditions or 
problems that necessitated a prolonged postopera- 
tive stay. For example, all 12 had ischemic ulcers 
before surgical treatment in contrast to only 43% of 
the patients with postoperative stays less than 14 
days. The incidence of diabetes (66%) and chronic 
renal failure necessitating dialysis (33%) was higher 
for the subset with prolonged postoperative stays 
compared with patients with postoperative stays 
shorter than 14 days (50% and 9%, respectively). 
More specifically, the prolonged stays for these 12 
patients were necessitated by one or more of the fol- 
lowing problems: an additional surgical procedure 
(extensive d~bridement or amputation), severe car- 
diac arrhythmia, perioperative myocardial infarction, 
ethanol withdrawal, respiratory failure caused by 
chronic pulmonary disease, or large postoperative 
hematoma. In essence, all these patients had preex- 
isting problems or postoperative complications that 
made adherence to the pathway impossible, and we 
were concerned that markedly prolonged lengths of 
stay among these patients masked the truc benefit of 
the pathway for most patients. Consequently, we 
repeated the multivariate analysis after estricting the 
data set to patients with postoperative stays less than 
14 days to assess the effect of the pathway without 
the bias introduced by complications that necessitat- 
ed long postoperative stays. 
Even after the data set was restricted to patients 
with postoperative lengths of stay less than 14 days, 
the pathway patients were comparable with the 
patients treated before institution of the pathway. 
Factors associated with prolonged length of stay in 
the complete data set also were related to length of 
postoperative stay in the restricted ata set. With the 
12 outliers removed, coronary artery disease, limb 
salvage as an indication for operation, tibial anasto- 
mosis, presence of any postoperative complication, 
low preoperative hematocrit, and elevated preopera- 
tive crcatininc levels wcrc associated with longer 
postoperative stays, although diabetes was no longer 
predictive of longer postoperative stay. 
When multivariate analysis was repeated after the 
data set was restricted to patients with stays less than 
14 days, factors associated with a significantly 
increased postoperative length of stay again included 
anastomosis to fibial vessels (as opposed to popliteal 
vessels, p = 0.02), preexisting coronary artery disease 
(p = 0.005), preoperative anemia (p = 0.04), elevated 
preoperative serum creatinine level (p = 0.006), and 
presence of any postoperative complication (p = 
0.0003). After adjustment for differences in these fac- 
tors, patients on the critical pathway had significantly 
shorter postoperative l ngths of stay (p = 0.001). 
Taken together, these factors accounted for 37% of 
the observed variability in postoperativc length of stay 
(R 2 = 0.37). Neither age nor urgency of operation 
had any significant effect on length of stay. 
Lack of adherence to the pathway. Progress 
on the pathway was tracked prospectively and 
recorded by a vascular nurse clinician. Among the 
patients on the critical pathway, 54% had a postop- 
erative length of stay longer than the 5-day stay out- 
fined by the pathway. Deviations from the pathway 
were attributed to one or more of four sources: 
patient, 32% (e.g., wound problems); clinician, 10% 
(i.e., attending surgeon's decision); system, 3% (e.g., 
scheduling errors, delays in obtaining consulta- 
JOURNAL OF VASCULAR SURGERY 
Volume 27, Number 6 Stanley et al. 1063 
tions); or community factors, 19% (e.g., no available 
bed in skilled nursing facility, rehabilitation center, 
or post-acute-care gency). 
DISCUSSION 
Economic pressures have fostered within the 
medical community an attitude of fiscal responsibil- 
ity and an awareness of issues related to length of 
stay and utilization of resources. At the outset our 
objective was to streamline the postoperative care of 
patients undergoing infrainguinal bypass and to 
eliminate unnecessary delays in discharge, but we 
were concerned that implementation of a pathway 
might have an adverse ffect on patient outcomes. 
Our findings suggested that implementation of a 
critical pathway was associated with a modest reduc- 
tion in postoperative l ngth of stay for patients 
undergoing infralnguinal bypass without adversely 
affecting mortality, morbidity, or frequency of read- 
mission. However, after adjustment for other factors 
influencing postoperative length of stay, the pathway 
had a significant benefit only if we excluded the 12 
patients who had extraordinarily ong postoperative 
stays because of certain medical and surgical compli- 
cations. There was also evidence to suggest that the 
ability of the pathway to help shorten postoperative 
stay was achieved primarily by discharging patients 
to intermediate-care facilities. 
An unbiased evaluation of a critical pathway in 
the care of patients undergoing peripheral vascular 
operations is complicated by the fact that patients 
with vascular disease vary widely with respect to the 
severity of their disease and in the spectrum and 
severity of comorbidities that can prolong hospital- 
ization. Other studies have dealt with this problem 
with exclusion of certain subpopulations in evalua- 
tions of the efficacy of a critical pathway.i, 4 We 
believe that the analytic approach we used is a fairer 
representation f the potential benefits and limita- 
tions of a critical pathway. Our findings indicate that 
postoperative stay in the acute-care facility was short- 
ened among patients with relatively uncomplicated 
stays but suggest little effect among the subset of 
patients with preexisting medical conditions that 
necessitated prolonged postoperative stays. It is 
important o note that the pathway patients were 
more frequently discharged to intermediate-care 
facilities, raising the possibility that the true effect 
was not to decrease the period during which care was 
needed but to provide care in a less intense setting. 
Comparison of the frequency distributions for 
length of stay before and after implementation f the 
pathway suggests that the principal effect was a 
modest shift toward shorter stays among the larger 
group of patients with relatively uncomplicated 
postoperative stays ranging from 2 to 12 days. In 
contrast, it is unlikely that the pathway had any 
effect on the smaller subset of patients who had 
postoperative problems that necessitated stays 
longer than 14 days. The postoperative stay for these 
patients was not going to be expedited by the path- 
way. An analysis that included these patients sug- 
gested that the pathway did not significantly shorten 
length of stay. However, an analysis focused on the 
large group of patients without conditions necessi- 
tating prolonged stays indicated that the pathway 
resulted in a highly significant decrease in postoper- 
ative hospitalization. 
It is important o note that none of the pro- 
longed hospital stays could be attributed to the 
pathway. Instead, the prolonged stays primarily were 
necessitated by preexisting cardiac, respiratory, or 
more complex vascular disease. All 12 of the patients 
with outlier status had open ulcers, many of which 
necessitated serial ddbridement after revasculariza- 
tion. Diabetes and renal failure necessitating dialysis 
also were more common among the 12 patients with 
stays longer than 14 days. Thirty-three percent of 
the patients with outlier status had diabetes and 
were undergoing dialysis. This population of 
patients has been shown to have reduced wound- 
healing capability and poor limb-salvage rates after 
infrainguinal bypass. 9 Our data suggest that the crit- 
ical pathway we established is probably not effective 
in the care of this subpopulation. It is possible that 
care of these patients would benefit from develop- 
ment of another pathway. Patients who undergo 
operations for claudication would be expected to 
have shorter postoperative stays than those operated 
on for limb salvage. Only 10% of our patients who 
underwent bypass operations did so for clandication, 
although in this series 15% of the prepathway 
patients and 22% of the pathway patients had claudi- 
cation. This may have contributed to the somewhat 
shorter stays of the pathway patients hown in Table 
III, although we adjusted for this factor in the mul- 
tivariate analysis. Nevertheless, it is important o 
consider the proportion of patients operated on for 
claudication versus limb salvage because this has an 
important effect on overall ength of stay. 
Another problem in evaluating the effect of a 
critical path is that randomized, clinical trials cannot 
realistically be conducted, and the most appropriate 
comparison group consists of patients at the same 
institution who were cared for immediately before 
implementation of the pathway. However, use of 
earlier patients as a comparison group is complicat- 
ed by the fact that many factors influence length of 
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stay, and the pathway patients may differ from the 
comparison group in important ways. Rhodes et 
al.10 found that increased age and more distal anas- 
tomosis were associated with longer lengths of stay. 
Kalman et al. ll found the indication for surgical 
treatment (limb salvage versus claudication) to be a 
significant predictor of length of stay. 
We found that both site of the distal anastomosis 
and the primary indication for surgical treatment 
were associated with length of stay, but multivariate 
analysis uggested that site of the distal anastomosis 
was the more important factor. Our analysis also indi- 
cated that other factors associated with length of stay 
were history of cardiac disease, diabetes, presence of 
a postoperative complication, elevated preoperative 
serum creatinine level, and low preoperative hemat- 
ocrit. We also found a positive correlation between 
postoperative stay and duration of epidural analgesia, 
although the explanation for the correlation is 
unclear. Another surprising observation in our study 
was that current smokers had somewhat shorter post- 
operative stays than nonsmokers. We speculate that 
patients with an addiction to nicotine are anxious to 
leave the strict smoke-free nvironment of a hospital. 
In evaluating the effect of this critical pathway we 
considered it important o demonstrate, first, that 
thc pathway patients and the prepathway comparison 
group were similar with respect o these factors and, 
second, that even when differences in these factors 
were taken into account in a multivariate analysis, the 
critical pathway was associated with a significantly 
shorter postoperative l ngth of stay. The pathway 
and prepathway patients did iffer in some ways. 
Pathway patients were more likely to have general 
anesthesia, although the type of anesthesia had no 
apparent effect on length of stay. Pathway patients 
were less likely to be discharged to home, even 
though the proportion of patients living alone was 
similar in both groups. This probably is the result of  
more aggressive attempts to discharge pathway 
patients to a non-acute-care s tting that still provides 
an appropriate level of interim care. In fact, the 
greater tendency to discharge patients to an interme- 
diate-care facility may account for much of the 
decreased postoperative stay we observed. Because 
we were unable to obtain information regarding 
intermediate-care after discharge from our service, it 
is impossible for us to comment about the effect of 
the critical pathway on overall hospitalization. It may 
be that care in an interim facility is less expensive than 
in an acute-care hospital. It remains to be seen 
whether a critical pathway would effectively diminish 
the overall cost ofinfrainguinal bypass. 
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D ISCUSSION 
Dr. Jack Cronenwet t  (Lebanon, N.H.).  You com- 
mented that more patients were being discharged to a 
rehabilitation center on the pathway than had previously 
been discharged to that type of facility. Although you may 
have reduced the length of stay, do you think that in some 
ways you are shifting cost to another institution, or do you 
think that on the original pathway ou just were not send- 
ing people to the appropriate discharge location? 
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Dr. Andrew C. Stanley. You are absolutely right. I 
think we are probably shifting cost. We set up this pro- 
gram basically to have our service work more efficiently. 
We did not do a cost analysis with this as we did in the first 
paper, but we do feel that the cost is probably shifted to
the rehabilitation i stitutions more so than the acute care 
hospital. 
Dr. Syed A. Razvi (Brighton, Mass.). I have a few 
comments. Dr. George LeMaltre mentioned this earlier. I 
think that one does have to separate wide open long inci- 
sions for bypass grafts versus emiclosed techniques. With 
the use of angioscopic valvulotomies, many patients with 
in situ grafts can go home in about 3 days on an average. 
This has been my experience. Also, I did not see that you 
looked at motivation of the patients. Much of the time, 
even before surgery, if patients are motivated to leave the 
hospital at an earlier date, I have found this to be an effec- 
tive method of having them ready for discharge. 
Obviously, a supportive family is helpful, but I think the 
socioeconomic conditions and the destination from the 
hospital also makes a difference in length of stay. I won- 
dered if you looked at any of those factors. 
Dr. Stanley. We did not look at those factors pecifical- 
ly, but I would, in turn, ask you a question. What did you 
use for motivation to discharge the patients from the hos- 
pital? 
Dr. Razvi. First, I think much of the blame can be put 
on the managed care companies. We tell the patients that 
they are only allowed to stay in the hospital for 3 days for 
this procedure. The stay will be on a day-to-day basis, and 
we have to justify the stay in the hospital for every day 
after that. Many patients who already dislike the managed 
care companies willingly accept hat explanation, which is 
true in many instances for patients with managed care 
companies that insist on documenting each and every day 
of stay. 
Dr. Daniel B. Walsh (Lebanon, N.H.). If  you look at 
our own risk factor data in our patients with infrainguinal 
bypass grafts, you might come to the conclusion that the 
savings occur only with people who have few risk factors 
and who are operated for clandication. Those people may 
be discharged from the hospital rather quickly. In our 
practice, for instance, 90% of the patients are operated for 
limb salvage and 60% of them have two or more risk fac- 
tors, such as coronary artery disease or diabetes. Few sav- 
ings appear achievable in that group. Is that correct? 
Dr. Stanley. I agree with you. 
Dr. Daniel R. Gorin (Manchester, N.H.). We have a 
situation with an inpatient acute care rehabilitation floor. 
When I started at the hospital, I was pleased to see that 
most of our patients were arriving there in less than 5 days. 
However, when we started looking at costs from the 
standpoint of a capitated contract, I was dismayed to find 
that the daily cost for a stay in that unit was absolutely 
identical to the daily cost of a stay in our acute care vascu- 
lar floor. I had thought that we were saving money. By 
instituting many of these other support personnel and try- 
ing to organize and discharge these patients more quickly 
perhaps we are spending more money. I do think, howev- 
er, that by looking at models like this we are delivering 
better patient care. The patients are receiving the rehabil- 
itation services that they should. So, we actually may be 
spending more money, but I think we are probably doing 
a better job. 
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